Norges Bank Rubius Therapeutics, Inc. Transaction History

Norges Bank

  • $655 Billion
  • Q2 2024

Shares

26 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

May 12, 2023
BUY
$4.25 - $10.4 $741,705 - $1.81 Million
174,519 New
174,519 $961,000
Q1 2022

May 09, 2022
SELL
$4.25 - $10.4 $741,705 - $1.81 Million
-174,519 Closed
0 $0
Q4 2021

Mar 09, 2022
BUY
$9.68 - $17.74 $1.69 Million - $3.1 Million
174,519 New
174,519 $1.69 Million
Q3 2021

Nov 14, 2022
BUY
$17.6 - $25.91 $3.07 Million - $4.52 Million
174,519 New
174,519 $3.12 Million
Q3 2021

Nov 05, 2021
SELL
$17.6 - $25.91 $3.07 Million - $4.52 Million
-174,519 Closed
0 $0
Q2 2021

Aug 15, 2022
BUY
$22.26 - $28.43 $3.88 Million - $4.96 Million
174,519 New
174,519 $4.26 Million
Q2 2021

Aug 10, 2021
SELL
$22.26 - $28.43 $8.46 Million - $10.8 Million
-380,000 Closed
0 $0
Q1 2021

May 09, 2022
BUY
$8.02 - $32.01 $3.05 Million - $12.2 Million
380,000 New
380,000 $10.1 Million
Q1 2021

May 07, 2021
SELL
$8.02 - $32.01 $3.61 Million - $14.4 Million
-450,000 Closed
0 $0
Q4 2020

Mar 02, 2021
BUY
$4.23 - $8.73 $1.9 Million - $3.93 Million
450,000 New
450,000 $3.42 Million
Q4 2020

Feb 10, 2021
SELL
$4.23 - $8.73 $1.9 Million - $3.93 Million
-450,000 Closed
0 $0
Q3 2020

Nov 12, 2021
BUY
$4.65 - $6.25 $2.09 Million - $2.81 Million
450,000 New
450,000 $2.26 Million
Q3 2020

Nov 10, 2020
SELL
$4.65 - $6.25 $2.09 Million - $2.81 Million
-450,000 Closed
0 $0
Q2 2020

Aug 13, 2021
BUY
$4.01 - $6.88 $1.8 Million - $3.1 Million
450,000 New
450,000 $2.69 Million
Q2 2020

Aug 07, 2020
SELL
$4.01 - $6.88 $1.8 Million - $3.1 Million
-450,000 Closed
0 $0
Q1 2020

May 07, 2021
BUY
$3.74 - $9.84 $1.68 Million - $4.43 Million
450,000 New
450,000 $2 Million
Q1 2020

May 08, 2020
SELL
$3.74 - $9.84 $1.68 Million - $4.43 Million
-450,000 Closed
0 $0
Q4 2019

Mar 03, 2020
BUY
$7.23 - $14.12 $3.25 Million - $6.35 Million
450,000 New
450,000 $4.28 Million
Q4 2019

Feb 12, 2020
SELL
$7.23 - $14.12 $3.25 Million - $6.35 Million
-450,000 Closed
0 $0
Q3 2019

Nov 13, 2020
BUY
$7.85 - $15.75 $3.53 Million - $7.09 Million
450,000 New
450,000 $3.53 Million
Q3 2019

Nov 08, 2019
SELL
$7.85 - $15.75 $3.53 Million - $7.09 Million
-450,000 Closed
0 $0
Q2 2019

Aug 13, 2020
BUY
$13.5 - $19.94 $6.08 Million - $8.97 Million
450,000 New
450,000 $7.08 Million
Q2 2019

Aug 09, 2019
SELL
$13.5 - $19.94 $6.08 Million - $8.97 Million
-450,000 Closed
0 $0
Q4 2018

Mar 04, 2019
BUY
$13.83 - $22.97 $6.22 Million - $10.3 Million
450,000 New
450,000 $7.24 Million
Q4 2018

Feb 08, 2019
SELL
$13.83 - $22.97 $6.22 Million - $10.3 Million
-450,000 Closed
0 $0
Q3 2018

Nov 12, 2019
BUY
$20.06 - $26.94 $9.03 Million - $12.1 Million
450,000 New
450,000 $10.8 Million

Others Institutions Holding RUBY

# of Institutions
2
Shares Held
325
Call Options Held
0
Put Options Held
0
View Full List

About Rubius Therapeutics, Inc.

RUBY Quotes by TradingView
  • Ticker RUBY
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 90,357,000
  • Description
  • Rubius Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development of red cell therapeutics (RCTs) for the treatment of patients with severe diseases. The company is developing RTX-240 and RTX-224 for the treatment of solid tumors cancer; and RTX-aAPC to treat cancers. It is also developing RTX-321 for the treatmen...
More about RUBY
Track This Portfolio

Track Norges Bank Portfolio

Follow Norges Bank and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Norges Bank, based on Form 13F filings with the SEC.

News

Stay updated on Norges Bank with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email